Live from the Global Virtual Conference on Shaping the Future of Malaria Research
Scientific Talk
Christopher Bower-Lepts, PhD, from Columbia University Irving Medical Center, USA, is presenting research at the 2026 Global Virtual Conference on Shaping the Future of Malaria Research.
Presentation Title: “A Plasmodium falciparum PX1 Haplotype Is Associated with Reduced Susceptibility to Artemisinin and Lumefantrine.”
The presentation examines genetic variation in Plasmodium falciparum associated with reduced susceptibility to two widely used antimalarial drugs, artemisinin and lumefantrine.
The research focuses on the association between the PX1 haplotype and reduced drug susceptibility, providing insights into antimalarial drug resistance and its implications for malaria treatment and surveillance.
Conference: MALARIA 2026 – Shaping the Future of Malaria Research
Speaker: Christopher Bower-Lepts, PhD
Institution: Columbia University Irving Medical Center
Country: USA
Research Area: Antimalarial Drug Resistance
Presentation: A Plasmodium falciparum PX1 Haplotype Is Associated with Reduced Susceptibility to Artemisinin and Lumefantrine
Date: June 29, 2026
Format: Online Conference
This conference is organized by Impact Research Communications (IRC)
More info: https://malaria.ircconferences.net/ | Global Malaria Research Initiative
